188 related articles for article (PubMed ID: 2965776)
1. Action of interferon-alpha on hairy cell leukemia: expression of specific receptors and (2'-5')oligo (A) synthetase in tumor cells from sensitive and resistant patients.
Billard C; Ferbus D; Sigaux F; Castaigne S; Degos L; Flandrin G; Falcoff E
Leuk Res; 1988; 12(1):11-8. PubMed ID: 2965776
[TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro induction of (2'-5') oligoadenylate synthetase by human interferons in leukocytes from healthy donors and patients with renal cancer and hairy cell leukemia.
Ferbus D; Billard C; Sigaux F; Thang MN; Falcoff E
J Biol Regul Homeost Agents; 1987; 1(3):147-53. PubMed ID: 2459906
[TBL] [Abstract][Full Text] [Related]
3. Interferons-alpha/beta- and -gamma-resistant Friend cell variants exhibiting receptor sites for interferons but no induction of 2-5A synthetase and 67K protein kinase.
Coccia EM; Federico M; Romeo G; Affabris E; Cofano F; Rossi GB
J Interferon Res; 1988 Feb; 8(1):113-27. PubMed ID: 2966842
[TBL] [Abstract][Full Text] [Related]
4. The interaction of interferon-alpha and -gamma: regulation of (2-5)A synthetase activity.
Fish EN; Hannigan GE; Banerjee K; Williams BR
Virology; 1988 Jul; 165(1):87-94. PubMed ID: 2455384
[TBL] [Abstract][Full Text] [Related]
5. Proliferative response of hairy cells to B cell growth factor (BCGF): in vivo inhibition by interferon-alpha and in vitro effects of interferon-alpha, -beta, and -gamma.
Genot E; Billard C; Sigaux F; Mathiot C; Degos L; Falcoff E; Kolb JP
Leukemia; 1987 Aug; 1(8):590-6. PubMed ID: 2444836
[TBL] [Abstract][Full Text] [Related]
6. Alpha-interferon receptors in malignant B-cells from patients with chronic lymphocytic leukemia: relation to induction of 2'-5'-oligoadenylate synthetase and blast transformation.
Ostlund L; Grandér D; Juliusson G; Robèrt KH; Lundgren E; Einhorn S
Cancer Res; 1989 Jun; 49(12):3425-30. PubMed ID: 2524252
[TBL] [Abstract][Full Text] [Related]
7. Lectins modulate the internalization of recombinant interferon-alpha A and the induction of 2',5'-oligo(A) synthetase.
Faltynek CR; Princler GL; Ruscetti FW; Birchenall-Sparks M
J Biol Chem; 1988 May; 263(15):7112-7. PubMed ID: 2966801
[TBL] [Abstract][Full Text] [Related]
8. In vivo sensitivity and resistance of chronic myelogenous leukemia cells to alpha-interferon: correlation with receptor binding and induction of 2',5'-oligoadenylate synthetase.
Rosenblum MG; Maxwell BL; Talpaz M; Kelleher PJ; McCredie KB; Gutterman JU
Cancer Res; 1986 Sep; 46(9):4848-52. PubMed ID: 2942242
[TBL] [Abstract][Full Text] [Related]
9. VIP induces in HT-29 cells 2'5'oligoadenylate synthetase and antiviral state via interferon beta/alpha synthesis.
Chelbi-Alix MK; Boissard C; Sripati CE; Rosselin G; Thang MN
Peptides; 1991; 12(5):1085-93. PubMed ID: 1724797
[TBL] [Abstract][Full Text] [Related]
10. Action of interferons in hairy cell leukemia.
Samuels BL; Rosner MC; Giometti CS; Golomb HM; Brownstein BH
Leukemia; 1987 Apr; 1(4):365-9. PubMed ID: 2444830
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hairy cell leukemia with recombinant alpha interferon: II. In vivo down-regulation of alpha interferon receptors on tumor cells.
Billard C; Sigaux F; Castaigne S; Valensi F; Flandrin G; Degos L; Falcoff E; Aguet M
Blood; 1986 Mar; 67(3):821-6. PubMed ID: 2936410
[TBL] [Abstract][Full Text] [Related]
12. Effects of combinations of interferon-beta ser and interferon-gamma on interferon-inducible proteins and on the cell cycle.
Schiller JH; Horisberger MA; Bittner G; Carlin JM; Storer B; Byrne GI; Willson JK; Borden EC
J Biol Response Mod; 1990 Aug; 9(4):368-77. PubMed ID: 2395002
[TBL] [Abstract][Full Text] [Related]
13. Induction of 2',5'-oligoadenylate synthetase in freshly separated malignant cells from solid tumors. Variability in the susceptibility of interferon.
Einhorn S; Vánky F; Grandér D; Willems JS
Eur J Cancer Clin Oncol; 1987 Nov; 23(11):1607-13. PubMed ID: 2448144
[TBL] [Abstract][Full Text] [Related]
14. Investigation of IFN type-I receptor and IFN regulatory factor expression relating to induction of 2', 5'-oligoadenylate synthetase in cells persistently infected with the mumps virus.
Fujii N; Yokosawa N; Ishida S; Shirakawa S; Kubota T; Indoh T; Fujinaga K; Yashiki T
Microbiol Immunol; 1996; 40(10):777-81. PubMed ID: 8981353
[TBL] [Abstract][Full Text] [Related]
15. Differential induction of 2',5'-oligoadenylate synthetase by IFN-beta ser and IFN-alpha 2 in serum-supplemented and serum-free HL-60 leukemic cell cultures.
Fraioli M; Wu JM
J Biol Regul Homeost Agents; 1989; 3(3):112-7. PubMed ID: 2624146
[TBL] [Abstract][Full Text] [Related]
16. Induction of intracellular and plasma 2',5'-oligoadenylate synthetase by pentostatin.
Ho AD; Klotzbücher A; Gross A; Dietz G; Mestan J; Jakobsen H; Hunstein W
Leukemia; 1992 Mar; 6(3):209-14. PubMed ID: 1564958
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to chromosome 21 coded cell surface components block binding of human alpha interferon but not gamma interferon to human cells.
Shulman LM; Kamarck ME; Slate DL; Ruddle FH; Branca AW; Baglioni C; Maxwell BL; Gutterman J; Anderson P; Nagler C; Vilcek J
Virology; 1984 Sep; 137(2):422-7. PubMed ID: 6237488
[TBL] [Abstract][Full Text] [Related]
18. Growth inhibitory effects of interferon-beta but not interferon-alpha on human glioma cells: correlation of receptor binding, 2',5'-oligoadenylate synthetase and protein kinase activity.
Rosenblum MG; Yung WK; Kelleher PJ; Ruzicka F; Steck PA; Borden EC
J Interferon Res; 1990 Apr; 10(2):141-51. PubMed ID: 2140395
[TBL] [Abstract][Full Text] [Related]
19. Immunological recovery and dose evaluation in IFN-alpha treatment of hairy cell leukemia: analysis of leukocyte differentiation antigens, NK and 2',5'-oligoadenylate synthetase activity.
Nielsen B; Hokland M; Justesen J; Hasselbalch H; Ellegaard J; Hokland P
Eur J Haematol; 1989 Jan; 42(1):50-9. PubMed ID: 2914594
[TBL] [Abstract][Full Text] [Related]
20. Protein binding to the interferon response enhancer correlates with interferon induction of 2'-5'-oligoadenylate synthetase in normal and interferon-resistant Friend cells.
Coccia EM; Vaiman D; Raber J; Marziali G; Fiorucci G; Orsatti R; Cohen B; Nissim N; Romeo G; Affabris E
J Virol; 1991 Apr; 65(4):2081-7. PubMed ID: 1705997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
